Brief: Oncternal Therapeutics Announces Fourth Quarter And Full Year 2022 Financial Results
09/03/2023 21:02
March 9 (Reuters) - Oncternal Therapeutics Inc ONCT.O :
* ONCTERNAL THERAPEUTICS PROVIDES BUSINESS UPDATE AND
ANNOUNCES
FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
* AS OF DECEMBER 31, 2022, WE HAD $63.7 MILLION IN CASH,
CASH
EQUIVALENTS
* QTRLY LOSS PER SHARE OF $0.20
* Q4 EARNINGS PER SHARE VIEW $-0.21 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX8tgMfj
Further company coverage: ONCT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;